ASU Hosts Nanotechnology Regulation Conference on March 21, 2011

Twenty-eleven is the year that regulation of nanotechnology will move from a hypothetical possibility to a real issue for companies in virtually every industry sector that are benefitting from the new science of nanotechnology.

Such regulation will raise profound policy, business and legal issues, which will be examined at a conference on March 21 sponsored by the Sandra Day O'Connor College of Law at Arizona State University.

"The Biggest Issues for the Smallest Stuff: Regulation and Risk Management of Nanotechnology" will be held from 8 a.m. to 5 p.m. at the Arizona Biltmore in Phoenix. It is co-hosted by the College of Law's Center for Law, Science & Innovation, The Center for Nanotechnology in Society at ASU, the law firm of Polsinelli Shughart PC, the ABA Section of Science & Technology, and the Arizona Nanotechnology Cluster, and is presented by Jurimetrics: The Journal of Law, Science, and Technology, an American Bar Association publication produced at the College of Law.

Known as the science of the small – the ability to manipulate and utilize materials at the "nanoscale" level where they display unique and beneficial characteristics – nanotechnology is a growing science with big implications for health, safety, quality of life and environmental concerns.

The conference will feature top national and international experts from government, industry, non-governmental organizations, the insurance industry and academia, including Steve Owens, Assistant Administrator at the Environmental Protection Agency, and Robert Falkner of the London School of Economics and LSE Global Governance.

Panel sessions and panelists include:

  • "The Regulatory Challenges of Nanotechnology"
    Nano Overview and Benefits: Vincent Caprio, Executive Director, NanoBusiness Alliance
    Scientific Challenges: Kiril Hristovski, Assistant Professor, College of Technology and Innovation, ASU
    Regulatory Challenges: Gary Marchant, Executive Director, Center for Law, Science & Innovation, and Lincoln Professor of Emerging Technologies, Law and Ethics, ASU
    Public Challenges: Elizabeth Corley, Associate Professor, School of Public Affairs, ASU

  • "Regulatory Agency Perspectives"
    Jeff Morris, National Program Director for Nanotechnology, EPA
    Charles Geraci, Coordinator, Nanotechnology Research Center, National Institute for Occupational Safety and Health
    Ritu Nalubola, Policy Analyst, U.S. Food and Drug Administration
    Jeffrey Wong, Chief Scientist, California Department of Toxic Substances Control, California Environmental Protection Agency

  • "Non-Regulatory Risk Management Approaches"
    Overview of Non-Regulatory Approaches, Daniel Fiorino, Executive in Residence, Department of Public Adminstration and Policy, American University
    EDF-Dupont NanoRisk Framework, Terry Medley, Global Director of Corporate Regulatory Affairs, DuPont
    Responsible NanoCode, Steffi Friedrichs, Director, Nanotechnology Industries Association
    European Code of Conduct, Rene VonSchomberg, European Union.

  • "Stakeholder Perspectives"
    NGO Perspective, Jennifer Sass, Senior Scientist, Health and Environment Program, Natural Resources Defense Council
    Legal Practitioner Perspective, John C. Monica Jr., Porter Wright.

  • "Is Liability in the Future of Nanotechnology?"
    Timothy F. Malloy, Professor and Faculty Director, Sustainable Technology and Policy Program, UCLA School of Law
    Edward R. Glady, Jr., Polsinelli Shughart, PC

Nanotechnology, the science of the very small, is a rapidly emerging set of technologies being applied in virtually every industry sector, including health care, energy, food, cosmetics, materials, computer and communication technologies, automotive, environmental services and many others. At the same time that nanotechnology is providing many new exciting applications and benefits, it also has the potential to create significant new risks for workers, consumers and the environment.

After several years of studying the problem, federal agencies such as EPA, FDA and NIOSH are now moving forward with more active regulation of nanotechnology while, at the same time, a variety of other non-regulatory risk management and safety initiatives are being proposed or implemented.

"The regulation and risk management of nanotechnology is likely to affect a large number of companies across the economy, given the increasing prevalence of nanotechnology," said Gary Marchant, Executive Director of the Center for Law, Science & Innovation, and Lincoln Professor of Emerging Technologies, Law and Ethics at ASU. "This conference presents a unique opportunity to hear from the top experts from around the world on how nanotechnology should be regulated and managed."

Registration is $75 (general), and $25 (ASU students and faculty), and CLE will be offered for $150 to private attorneys and $100 to public attorneys.

Source: http://www.asu.edu/

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Arizona State University. (2019, February 12). ASU Hosts Nanotechnology Regulation Conference on March 21, 2011. AZoNano. Retrieved on December 10, 2024 from https://www.azonano.com/news.aspx?newsID=21760.

  • MLA

    Arizona State University. "ASU Hosts Nanotechnology Regulation Conference on March 21, 2011". AZoNano. 10 December 2024. <https://www.azonano.com/news.aspx?newsID=21760>.

  • Chicago

    Arizona State University. "ASU Hosts Nanotechnology Regulation Conference on March 21, 2011". AZoNano. https://www.azonano.com/news.aspx?newsID=21760. (accessed December 10, 2024).

  • Harvard

    Arizona State University. 2019. ASU Hosts Nanotechnology Regulation Conference on March 21, 2011. AZoNano, viewed 10 December 2024, https://www.azonano.com/news.aspx?newsID=21760.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.